The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats

Drug and Alcohol Dependence

Volumn 132, Issue 3, 2013, Pages 414-419

  Crawford, Jordan T ^a   Roberts, David C S ^a   Beveridge, Thomas J R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Extended access; LY369268; Methamphetamine; Self administration

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; METHAMPHETAMINE; SODIUM CHLORIDE; SUCROSE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SELF ADMINISTRATION; DRUG USE; MALE; METHAMPHETAMINE DEPENDENCE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALIA; RATTUS;

EXTENDED-ACCESS; LY369268; METHAMPHETAMINE; SELF-ADMINISTRATION;

AMINO ACIDS; ANIMALS; BEHAVIOR, ADDICTIVE; BICYCLO COMPOUNDS, HETEROCYCLIC; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; SELF ADMINISTRATION;

EID: 84883559648     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.07.024     Document Type: Article

References (58)

1. Adewale A.S., Platt D.M., Spealman R.D. Pharmacological stimulation of group II metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys. J. Pharmacol. Exp. Ther. 2006, 318:922-931.
2. Ahmed S.H., Koob G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 1998, 282:298-300.
3. Ahmed S.H., Koob G.F. Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function. Psychopharmacology (Berl) 2005, 180:473-490.
4. American Psychological Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-R) 2000, APA, Washington, DC.
5. Backstrom P., Hyytia P. Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG. Eur. J. Pharmacol. 2005, 528:110-118.
6. Baptista M.A., Martin-Fardon R., Weiss F. Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer. J. Neurosci. 2004, 24:4723-4727.
7. Beveridge T.J., Smith H.R., Nader M.A., Porrino L.J. Group II metabotropic glutamate receptors in the striatum of non-human primates: dysregulation following chronic cocaine self-administration. Neurosci. Lett. 2011, 496:15-19.
8. Bossert J.M., Busch R.F., Gray S.M. The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking. Neuroreport 2005, 16:1013-1016.
9. Bossert J.M., Gray S.M., Lu L., Shaham Y. Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking. Neuropsychopharmacology 2006, 31:2197-2209.
10. Brennan K.A., Colussi-Mas J., Carati C., Lea R.A., Fitzmaurice P.S., Schenk S. Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the rat. Brain Res. 2010, 1317:137-146.
11. Cartmell J., Monn J.A., Schoepp D.D. Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 361:39-46.
12. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 1997, 37:205-237.
13. Cornish J.L., Duffy P., Kalivas P.W. A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience 1999, 93:1359-1367.
14. Dalley J.W., Lääne K., Theobald D.E., Peña Y., Bruce C.C., Huszar A.C., Wojcieszek M., Everitt B.J., Robbins T.W. Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine. Neuropsychopharmacology 2007, 32:1195-1206.
15. Dietrich D., Kral T., Clusmann H., Friedl M., Schramm J. Presynaptic group II metabotropic glutamate receptors reduce stimulated and spontaneous transmitter release in human dentate gyrus. Neuropharmacology 2002, 42:297-305.
16. Eshleman A.J., Carmolli M., Cumbay M., Martens C.R., Neve K.A., Janowsky A. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J. Pharmacol. Exp. Ther. 1999, 289:877-885.
17. Florin S.M., Kuczenski R., Segal D.S. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Brain Res. 1994, 654(1):53-62.
18. George O., Mandyam C.D., Wee S., Koob G.F. Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology 2008, 33:2474-2482.
19. Gonzalez Castro F., Barrington E.H., Walton M.A., Rawson R.A. Cocaine and methamphetamine: differential addiction rates. Psychol. Addict. Behav. 2000, 14:390-396.
20. Graves S.M., Napier T.C. Mirtazapine alters cue-associated methamphetamine seeking in rats. Biol. Psychiatry 2011, 69:275-281.
21. Hao Y., Martin-Fardon R., Weiss F. Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Biol. Psychiatry 2010, 68:240-248.
22. Higley A.E., Kiefer S.W., Li X., Gaal J., Xi Z.X., Gardner E.L. Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats. Eur. J. Pharmacol. 2011, 659:187-192.
23. Hu G., Duffy P., Swanson C., Ghasemzadeh M.B., Kalivas P.W. The regulation of dopamine transmission by metabotropic glutamate receptors. J. Pharmacol. Exp. Ther. 1999, 289:412-416.
24. Hurd Y.L., Ungerstedt U. Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse 1989, 3(1):48-54.
25. Institute of Laboratory Animal Resources Guide for the care anduse of laboratory animals 1996, National Academy, Washington, DC.
26. Karasawa J., Yoshimizu T., Chaki S. A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell. Neurosci. Lett. 2006, 393:127-130.
27. Kim J.H., Vezina P. The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine. Pharmacol. Biochem. Behav. 2002, 73:333-337.
28. Kim J.H., Austin J.D., Tanabe L., Creekmore E., Vezina P. Activation of group II mGlu receptors blocks the enhanced drug taking induced by previous exposure to amphetamine. Eur. J. Neurosci. 2005, 21:295-300.
29. Kitamura O., Wee S., Specio S.E., Koob G.F., Pulvirenti L. Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology (Berl) 2006, 186:48-53.
30. Kuczenski R., Segal D.S., Cho A.K., Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 1995, 15:1308-1317.
31. Kufahl P.R., Watterson L.R., Nemirovsky N.E., Hood L.E., Villa A., Halstengard C., Zautra N., Olive M.F. Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration. Neuropharmacology 2013, 66:290-301.
32. Liu Y., Roberts D.C., Morgan D. Effects of extended-access self-administration and deprivation on breakpoints maintained by cocaine in rats. Psychopharmacology (Berl) 2005, 179:644-651.
33. Mark K.A., Soghomonian J.J., Yamamoto B.K. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J. Neurosci. 2004, 24:11449-11456.
34. McFarland K., Lapish C.C., Kalivas P.W. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 2003, 23:3531-3537.
35. Meyer A.C., Horton D.B., Neugebauer N.M., Wooters T.E., Nickell J.R., Dwoskin L.P., Bardo M.T. Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology 2011, 61:849-856.
36. Monn J.A., Valli M.J., Massey S.M., Hansen M.M., Kress T.J., Wepsiec J.P., Harkness A.R., Grutsch J.L., Wright R.A., Johnson B.G., Andis S.L., Kingston A., Tomlinson R., Lewis R., Griffey K.R., Tizzano J.P., Schoepp D.D. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. J. Med. Chem. 1999, 42:1027-1040.
37. Moussawi K., Kalivas P.W. Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction. Eur. J. Pharmacol. 2010, 639:115-122.
38. Nash J.F., Yamamoto B.K. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 1992, 581:237-243.
39. Nicosia N., Liccardo, Pacula R., Koilmer B., Lundberg R., Chiesa J. The Economic Cost of Methamphetamine Use in the United States 2005, RAND (Drug Policy Research Center).
40. Orio L., Wee S., Newman A.H., Pulvirenti L., Koob G.F. The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access. Addict. Biol. 2010, 15:312-323.
41. Parsegian A., Glen W.B., Lavin A., See R.E. Methamphetamine self-administration produces attentional set-shifting deficits and alters prefrontal cortical neurophysiology in rats. Biol. Psychiatry 2011, 69:253-259.
42. Peters J., Kalivas P.W. The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats. Psychopharmacology (Berl) 2006, 186:143-149.
43. Quadros I.M., Miczek K.A. Two modes of intense cocaine bingeing: increased persistence after social defeat stress and increased rate of intake due to extended access conditions in rats. Psychopharmacology (Berl) 2009, 206(1):109-120.
44. Reichel C.M., Schwendt M., McGinty J.F., Olive M.F., See R.E. Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology 2011, 36:782-792.
45. Reichel C.M., Chan C.H., Ghee S.M., See R.E. Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats. Psychopharmacology (Berl) 2012, 223:371-380.
46. Richardson N.R., Roberts D.C. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Methods 1996, 66:1-11.
47. Roberts D.C., Morgan D., Liu Y. How to make a rat addicted to cocaine. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:1614-1624.
48. SAMHSA (Substance Abuse and Mental Health Services Administration) Drug Abuse Warning Network, 2006 2008, National Estimates of Drug-Related Emergency Department Visits, Rockville, MD.
49. SAMHSA (Substance Abuse and Mental Health Services Administration) United States Department of Health and Human Services 2008, Office of Applied Studies. National Survey on Drug Use and Health, Ann Arbor, MI.
50. Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther. 2001, 299:12-20.
51. Schwendt M., Rocha A., See R.E., Pacchioni A.M., McGinty J.F., Kalivas P.W. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J. Pharmacol. Exp. Ther. 2009, 331:555-562.
52. Sora I., Li B., Fumushima S., Fukui A., Arime Y., Kasahara Y., Tomita H., Ikeda K. Monoamine transporter as a target molecule for psychostimulants. Int. Rev. Neurobiol. 2009, 85:29-33.
53. Stephans S.E., Yamamoto B.K. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 1994, 17:203-209.
54. Stuber G.D., Hnasko T.S., Britt J.P., Edwards R.H., Bonci A. Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. J. Neurosci. 2010, 30:8229-8233.
55. Takamatsu Y., Yamamoto H., Ogai Y., Hagino Y., Markou A., Ikeda K. Fluoxetine as a potential pharmacotherapy for methamphetamine dependence: studies in mice. Ann. N.Y. Acad. Sci. 2006, 1074:295-302.
56. Tecuapetla F., Patel J.C., Xenias H., English D., Tadros I., Shah F., Berlin J., Deisseroth K., Rice M.E., Tepper J.M., Koos T. Glutamatergic signaling by mesolimbic dopamine neurons in the nucleus accumbens. J. Neurosci. 2010, 30:7105-7110.
57. Wee S., Wang Z., Woolverton W.L., Pulvirenti L., Koob G.F. Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration. Neuropsychopharmacology 2007, 32:2238-2247.
58. Xi Z.X., Baker D.A., Shen H., Carson D.S., Kalivas P.W. Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens. J. Pharmacol. Exp. Ther. 2002, 300:162-171.